Primary open-angle glaucoma (POAG) is a chronic ocular disease characterized by an open-angle of the anterior chamber and atrophy of the optic nerve, resulting in blindness. Increased intraocular pressure (IOP) is a major risk factor for glaucoma. According to the American Academy of Ophthalmology (AAO), the prevalence of glaucoma is expected to increase by 50% in 2040. This World Glaucoma Week, we share the recent guidelines given by the AAO for the medical management of POAG.
AAO guidelines, 2020 for the medical management of POAG Eye-drops containing prostaglandin analogs (administered only once daily ) are the initial medical therapy for lowering IOP due to their efficacy and tolerability. Topical beta-adrenergic antagonists are effective and well-tolerated , and may be administered once or twice daily. However, dosing beta-blockers at night lowers their efficacy. An alternative…
